United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspire pharma ltd - bimatoprost - eye drops - 300microgram/1ml

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - bimatoprost - eye drops, solution - bimatoprost 0.1 mg/ml - ophthalmologicals

Malta - English - Medicines Authority

accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - bimatoprost - eye drops, solution - bimatoprost 0.3 mg/ml - ophthalmologicals

Ireland - English - HPRA (Health Products Regulatory Authority)

aspire pharma limited - bimatoprost - eye drops, solution - 0.3 milligram(s)/millilitre - bimatoprost

Israel - English - Ministry of Health

k.s.kim international (sk- pharma) ltd., israel - bimatoprost - ophthalmic solution - bimatoprost 0.3 mg / 1 ml - bimatoprost - reduction of elevated intraocular pressure in chronic open angle glaucoma and ocular hypertension (as monotherapy or as adjunctive therapy to beta-blockers).

Ireland - English - HPRA (Health Products Regulatory Authority)

european regulatory affairs t/a ivowen - bimatoprost - eye drops, solution - 0.3 milligram(s)/millilitre - bimatoprost

Ireland - English - HPRA (Health Products Regulatory Authority)

farmaprojects s.a. - bimatoprost - eye drops, solution - bimatoprost

Ireland - English - HPRA (Health Products Regulatory Authority)

laboratoires thea - bimatoprost - eye gel in single-dose container - bimatoprost

Ireland - English - HPRA (Health Products Regulatory Authority)

morningside healthcare (malta) limited - bimatoprost - eye drops, solution - bimatoprost

Israel - English - Ministry of Health

allergan israel ltd - bimatoprost 0.03 %w/v - ophthalmic solution - bimatoprost - latisse is indicated to treat hypotrichosis of the eyelashes by increasing their growth including length, thickness and darkness. latisse should not be used longer than 6 months.